Success Metrics

Clinical Success Rate
72.7%

Based on 16 completed trials

Completion Rate
73%(16/22)
Active Trials
1(4%)
Results Posted
56%(9 trials)
Terminated
6(22%)

Phase Distribution

Ph not_applicable
4
15%
Ph phase_3
5
19%
Ph phase_2
6
22%
Ph phase_4
12
44%

Phase Distribution

0

Early Stage

6

Mid Stage

17

Late Stage

Phase Distribution27 total trials
Phase 2Efficacy & side effects
6(22.2%)
Phase 3Large-scale testing
5(18.5%)
Phase 4Post-market surveillance
12(44.4%)
N/ANon-phased studies
4(14.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.7%

16 of 22 finished

Non-Completion Rate

27.3%

6 ended early

Currently Active

1

trials recruiting

Total Trials

27

all time

Status Distribution
Active(3)
Completed(16)
Terminated(6)
Other(2)

Detailed Status

Completed16
Terminated6
unknown2
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
1
Success Rate
72.7%
Most Advanced
Phase 4

Trials by Phase

Phase 26 (22.2%)
Phase 35 (18.5%)
Phase 412 (44.4%)
N/A4 (14.8%)

Trials by Status

completed1659%
terminated622%
unknown27%
active_not_recruiting14%
not_yet_recruiting27%

Recent Activity

1 active trials
Showing 5 of 27
not_yet_recruitingphase_4

Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH

NCT07856056
terminatednot_applicable

Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia

NCT00547703
not_yet_recruitingphase_4

Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)

NCT07655440
completedphase_2

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

NCT03844412
active_not_recruitingphase_4

Management of Acute Tinnitus With Migraine Medications

NCT06799169
View all 27 trials

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT07856056Phase 4

Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH

Not Yet Recruiting
NCT00547703Not Applicable

Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia

Terminated
NCT07655440Phase 4

Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)

Not Yet Recruiting
NCT03844412Phase 2

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Completed
NCT06799169Phase 4

Management of Acute Tinnitus With Migraine Medications

Active Not Recruiting
NCT04226365Phase 4

Pediatric Concussion Outcomes

Terminated
NCT03652571Phase 3

Nortriptyline for the Treatment of Functional Dyspepsia

Terminated
NCT03652870Phase 3

Antidepressants Trial in Parkinson's Disease

Completed
NCT02169830Not Applicable

Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine

Terminated
NCT02918097Phase 4

Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode

Completed
NCT02901249Phase 4

Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder

Completed
NCT02260388Phase 4

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations

Completed
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated
NCT00009672Phase 2

Pain Treatment for Sciatica

Completed
NCT00062738Phase 2

Treatment of Depression in Parkinson's Disease Trial

Completed
NCT00000378Phase 4

Antidepressant Treatment of Melancholia in Late Life

Completed
NCT00660062Phase 4

Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)

Terminated
NCT02237937Phase 4

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene

Unknown
NCT00045916Phase 4

Optimizing Electroconvulsive Therapy for Depression

Completed
NCT01896349Not Applicable

Interpersonal Psychotherapy for Treatment Resistant Depression

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
27